Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Dong

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Affective Disorders|February 20, 2024
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)Donel M Martin, Anna J Harvey, Bernard Baune, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
Journal of Affective Disorders|February 15, 2020
Development of the Ketamine Side Effect Tool (KSET)Brooke Short, Vanessa Dong, Verònica Gálvez, et al.
The Journal of ECT|June 29, 2017
The Clinical Alliance and Research in Electroconvulsive Therapy Network: An Australian Initiative for Improving Service Delivery of Electroconvulsive TherapyDonel M Martin, Verònica Gálvez, Shani Lauf, et al.
Journal of Affective Disorders|September 10, 2025
Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatmentClara Massaneda-Tuneu, Donel Martin, Nicholas Glozier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Affective Disorders|February 20, 2024
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)Donel M Martin, Anna J Harvey, Bernard Baune, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
Journal of Affective Disorders|February 15, 2020
Development of the Ketamine Side Effect Tool (KSET)Brooke Short, Vanessa Dong, Verònica Gálvez, et al.
The Journal of ECT|June 29, 2017
The Clinical Alliance and Research in Electroconvulsive Therapy Network: An Australian Initiative for Improving Service Delivery of Electroconvulsive TherapyDonel M Martin, Verònica Gálvez, Shani Lauf, et al.
Journal of Affective Disorders|September 10, 2025
Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatmentClara Massaneda-Tuneu, Donel Martin, Nicholas Glozier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Pageof 2